General Information of Target

Target ID LDTP10364
Target Name Brevican core protein (BCAN)
Gene Name BCAN
Gene ID 63827
Synonyms
BEHAB; CSPG7; Brevican core protein; Brain-enriched hyaluronan-binding protein; BEHAB; Chondroitin sulfate proteoglycan 7
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MEVDINGESRSTLTTLPFPGAEANSPGKAEAEKPRCSSTPCSPMRRTVSGYQILHMDSNY
LVGFTTGEELLKLAQKCTGGEESKAEAMPSLRSKQLDAGLARSSRLYKTRSRYYQPYEIP
AVNGRRRRRMPSSGDKCTKSLPYEPYKALHGPLPLCLLKGKRAHSKSLDYLNLDKMIKEP
ADTEVLQYQLQHLTLRGDRVFARNNT
Target Bioclass
Immunoglobulin
Family
Aggrecan/versican proteoglycan family
Subcellular location
Secreted; Secreted, extracellular space, extracellular matrix; Membrane; Lipid-anchor, GPI-anchor
Function May play a role in the terminally differentiating and the adult nervous system during postnatal development. Could stabilize interactions between hyaluronan (HA) and brain proteoglycans.
Uniprot ID
Q96GW7
Ensemble ID
ENST00000329117.10
HGNC ID
HGNC:23059

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
A375 SNV: p.D749E .
AN3CA SNV: p.A195V .
DU145 SNV: p.E665Ter .
FTC133 SNV: p.R347H .
HCT15 SNV: p.E378D .
IM95 SNV: p.R402C .
IPC298 SNV: p.D119N .
JURKAT Deletion: p.A646HfsTer210 .
KYSE30 SNV: p.G659E .
KYSE410 SNV: p.S814C .
LS180 SNV: p.A43V .
MCC13 SNV: p.G566R .
MCC26 SNV: p.P546L .
MELJUSO SNV: p.E477A .
MEWO SNV: p.P66Q .
MOLT4 SNV: p.R38C .
NCIH1299 SNV: p.V120G .
NCIH1793 SNV: p.P265Q .
NCIH1944 SNV: p.R605T .
NCIH358 SNV: p.S132L .
NCIH716 SNV: p.P65T .
OVK18 SNV: p.G51S .
SKMEL30 SNV: p.I182S DBIA    Probe Info 
SKNSH SNV: p.P44Q .
SW1116 SNV: p.E190D .
TOV21G SNV: p.A369T .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C352(3.32)  LDD3428  [1]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0022  KB02 G-361 C352(2.04)  LDD2329  [1]
 LDCM0023  KB03 G-361 C352(3.17)  LDD2746  [1]
 LDCM0024  KB05 SK-MEL3 C352(3.32)  LDD3428  [1]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840